A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine containing the 2013/2014 Formulation of Enzira® vaccine in Healthy Volunteers

Registry ID

EUCTR2013-001420-19

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

bioCSL Pty Ltd

Start date

2013-05-23

Completion date

2013-06-21

Last update

2026-08-16

Conditions

• Influenza, human

Summary

To evaluate the immunogenicity of the study vaccine in healthy adults aged 18 to 60 years according to the criteria outlined in the CPMP Note for Guidance on Harmonisation of Requirements for Influenza Vaccines (CPMP/BWP/214/96).

Locations

• , , UK

View on source registry